Cargando…
Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase
Prostate cancer is the most commonly diagnosed non-cutaneous cancer and one of the leading causes of cancer death for North American men. Whereas localized prostate cancer can be cured, there is currently no cure for metastatic prostate cancer. Here we report a novel approach that utilizes designed...
Autores principales: | Li, Ke, Pang, Jun, Cheng, Huaiyan, Liu, Wei-Peng, Di, Jin-Ming, Xiao, Heng-Jun, Luo, Yun, Zhang, Hao, Huang, Wen-Tao, Chen, Ming-Kun, Li, Liao-Yuan, Shao, Chun-Kui, Feng, Ying-Hong, Gao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496338/ https://www.ncbi.nlm.nih.gov/pubmed/25888628 |
Ejemplares similares
-
Fibrosis—the tale of H3K27 histone methyltransferases and demethylases
por: Basta, Morgan D., et al.
Publicado: (2023) -
Inhibitors of Protein Methyltransferases and Demethylases
por: Kaniskan, H. Ümit, et al.
Publicado: (2017) -
Combined analysis of CRMP4 methylation levels and CAPRA-S score predicts metastasis and outcomes in prostate cancer patients
por: Huang, Qun-Xiong, et al.
Publicado: (2018) -
Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase
por: Xia, Zhen, et al.
Publicado: (2021) -
Histone methyltransferases and demethylases: regulators in balancing osteogenic and adipogenic differentiation of mesenchymal stem cells
por: Deng, Peng, et al.
Publicado: (2015)